By
Treatment Action Group
Published: Sept. 28, 2014, 10:58 p.m.·
Tags:
Advocacy
Both guides describe what activists—including people with TB, researchers, and doctors who treat TB—can do to help ensure access, fair pricing, and further research.
Read More →
By
World Health Organization,
International Union Against Tuberculosis and Lung Disease
Published: Sept. 28, 2014, 10:24 p.m.·
Tags:
Pediatrics,
TB programs
The training focuses on building the capacity of health care workers at the primary and secondary level to address and manage TB in children.
Read More →
By
International Union Against Tuberculosis and Lung Disease
Published: Sept. 28, 2014, 10:07 p.m.·
Tags:
Events
WHO to release annual Global Tuberculosis Report in advance of the event; Looming co-epidemic of TB and diabetes to be a major focus of the conference; 1st international parliamentarian TB summit to precede the conference.
Read More →
By
The White House
Published: Sept. 28, 2014, 9:19 p.m.·
Tags:
Global TB response,
Drug-resistant TB
President Obama signed an Executive Order directing key Federal departments and agencies to take action to combat the rise of antibiotic-resistant bacteria.
Read More →
By
Janssen
Published: Sept. 22, 2014, 8:26 p.m.·
Tags:
Advocacy,
Access,
Drug-resistant TB
Several organizations and individuals working on TB appealed to Janssen to lower bedaquiline's price for all non-high-income countries.
Read More →
By
Sveta McGill
Published: Sept. 12, 2014, 8:19 p.m.·
Tags:
HIV coinfection
TB is both the most significant AIDS-related disease and the leading cause of death in PLHIV in Ukraine. The dual epidemics of TB and HIV continue to have significant impacts in the country, and pose multiple challenges for effective management and treatment of people living with HIV and TB.
Read More →
By
civil society
Published: Sept. 10, 2014, 11:51 p.m.·
Tags:
Advocacy,
Access,
Drug-resistant TB
Several organizations and individuals working on TB appeal to Janssen to lower bedaquiline's price for all non-high-income countries.
Read More →
By
Theo Smart
Published: Sept. 10, 2014, 6:16 p.m.·
Tags:
Treatment,
Drug-sensitive TB
Two 4-month treatment regimens containing moxifloxacin are less effective than the standard 6-month regimen for drug-sensitive tuberculosis.
Read More →
By
The Lancet Diabetes & Endocrinology
Published: Sept. 4, 2014, 11:24 a.m.·
Tags:
Diabetes,
Global TB response
A Series of three papers in The Lancet Diabetes & Endocrinology examines the intersection between TB and diabetes from several angles, and outlines strategies that will be key to managing and ultimately reducing this dual disease burden.
Read More →
Published: Sept. 1, 2014, 10:26 p.m.·
Tags:
HIV coinfection,
Diagnostics,
Pediatrics
A newly developed test (TAM-TB assay) is the first reliable immunodiagnostic assay to detect active tuberculosis in children.
Read More →
Page 91 of 133 · Total posts: 10
←First
90
91
92
Last→